Sangamo Therapeutics announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease

Presentation

Multiplex targeting of immune checkpoints with compact zinc finger repressors to improve anti-tumor activity of T cells

Download PDF